MIR4713HG

Across TCGA pan-cancer cohorts, MIR4713HG RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of MIR4713HG’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where MIR4713HG RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4713HG is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

HNSC, COAD, and LUSC are the cancer types where MIR4713HG tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4713HG RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Female	IV	+2.383	<.001	12	view →
COAD	All	IV	+1.400	<.001	11	view →
LUSC	Female	II,III,IV	+1.964	<.001	9	view →
STAD	All	All	+0.985	<.001	8	view →
LUAD	Male	All	+0.959	<.001	8	view →
BLCA	All	All	+0.850	.004	6	view →
BRCA	Female	II,III,IV	+0.307	<.001	6	view →
READ	All	III,IV	+1.940	.002	5	view →
KIRC	Male	III,IV	−0.027	.022	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

MIR4713HG–HNSC

Open the HNSC breakdown →